Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

[Comparison of three methods of antithrombotic therapy in elderly patients with nonvalvular atrial fibrillation].

Shevelev VI, Kanorskiń≠ SG.

Kardiologiia. 2012;52(7):56-60. Russian.

PMID:
22839715
2.

Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.

Uchiyama S, Ibayashi S, Matsumoto M, Nagao T, Nagata K, Nakagawara J, Tanahashi N, Tanaka K, Toyoda K, Yasaka M.

J Stroke Cerebrovasc Dis. 2012 Apr;21(3):165-73. doi: 10.1016/j.jstrokecerebrovasdis.2012.01.011. Review.

PMID:
22440950
3.

[Dabigatran eteksilat new anticoagulant for the prevention of stroke in patients with atrial fibrillation without valvular lesions].

Panchenko EP.

Kardiologiia. 2011;51(11):83-90. Review. Russian. No abstract available.

PMID:
22117775
4.

Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.

Berman JP, Halperin JL.

Hosp Pract (1995). 2013 Feb;41(1):37-48. doi: 10.3810/hp.2013.02.1006. Review.

PMID:
23466966
5.

An update on antithrombotic therapy in atrial fibrillation: the role of newer and emergent drugs.

Deedwania P, Huang GW.

Rev Cardiovasc Med. 2012;13(2-3):e89-104. Review.

PMID:
23160166
6.

Home-monitoring of oral anticoagulation vs. dabigatran. An indirect comparison.

Alonso-Coello P, Zhou Q, Guyatt G.

Thromb Haemost. 2012 Oct;108(4):647-53. Epub 2012 Aug 23. Review.

PMID:
22918481
7.

Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA).

Pengo V, Crippa L, Falanga A, Finazzi G, Marongiu F, Palareti G, Poli D, Testa S, Tiraferri E, Tosetto A, Tripodi A, Manotti C; Italian Federation of Thrombosis Centers.

Thromb Haemost. 2011 Nov;106(5):868-76. doi: 10.1160/TH11-05-0358. Epub 2011 Sep 22. Review.

PMID:
21946939
8.

Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.

Harenberg J, Marx S, Diener HC, Lip GY, Marder VJ, Wehling M, Weiss C.

Int Angiol. 2012 Aug;31(4):330-9. Review.

PMID:
22801398
9.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.

Potpara TS, Polovina MM, Licina MM, Stojanovic RM, Prostran MS, Lip GY.

Adv Ther. 2012 Jun;29(6):491-507. doi: 10.1007/s12325-012-0026-8. Epub 2012 Jun 7. Review.

PMID:
22684583
10.

New evidences for old concerns with oral anticoagulation in atrial fibrillation: focus on dabigatran.

Barrios V, Escobar C.

Expert Opin Pharmacother. 2012 Dec;13(18):2649-61. doi: 10.1517/14656566.2012.749860. Epub 2012 Nov 20. Review.

PMID:
23167273
11.

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.

Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2011 Jan-Feb;27(1):74-90. doi: 10.1016/j.cjca.2010.11.007.

PMID:
21329865
12.

A review of oral anticoagulants in patients with atrial fibrillation.

Greenspon AJ.

Postgrad Med. 2012 Nov;124(6):7-16. doi: 10.3810/pgm.2012.11.2608. Review.

PMID:
23322134
13.

[Dabigatran, a new oral anticoagulant].

Uchiyama S.

Brain Nerve. 2011 Apr;63(4):411-5. Review. Japanese.

PMID:
21441645
14.

Emerging oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation.

Destephan C, Waller AH, Patel RJ, Dhruvakumar S, Mazza V, Gerula C, Maher J, Kaluski E.

Minerva Cardioangiol. 2012 Aug;60(4):425-31. Review.

PMID:
22858920
15.

Dabigatran for stroke prevention in nonvalvular atrial fibrillation: focus in the geriatric population.

Brunetti L, Chen C, White J.

Consult Pharm. 2014 Mar;29(3):169-78. doi: 10.4140/TCP.n.2014.169. Review.

PMID:
24589766
16.

Challenges in atrial fibrillation.

Pisters R, Ten Cate H, Crijns HJ.

Adv Cardiol. 2012;47:155-64. doi: 10.1159/000338058. Epub 2012 Aug 9. Review.

PMID:
22906910
17.
18.

[Preventing cerebrovascular accidents during atrial fibrillation].

Ederhy S, Meuleman C, Hammoudi N, Janower S, Boccara F, Cohen A.

Presse Med. 2005 Oct 22;34(18):1315-24. Review. French.

PMID:
16269996
19.

Triple antithrombotic therapy with aspirin, a thienopyridine derivative plus oral anticoagulation in patients with atrial fibrillation undergoing coronary stenting.

Pipilis A, Lazaros G, Tsakonas G, Stefanadis C.

Hellenic J Cardiol. 2010 Jul-Aug;51(4):330-7. Review. No abstract available.

20.

Oral antithrombotic therapy in atrial fibrillation associated with acute or chronic coronary artery disease.

Cairns JA, McMurtry MS.

Can J Cardiol. 2013 Jul;29(7 Suppl):S60-70. doi: 10.1016/j.cjca.2013.04.006. Review.

PMID:
23790600
Items per page

Supplemental Content

Write to the Help Desk